ALS Clinical Trials in Houston

Showing 41-54 of 54 trials

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

NCT01083667

The objective of this study will be to evaluate the safety, tolerability and effect on SOD1 levels by pyrimethamine in patients with familial amyotrophic lateral sclerosis.

Familial Amyotrophic Lateral Sclerosis

Weill Medical College of Cornell University32 participantsStarted Nov 2009

New York, New York, United States • Houston, Texas, United States • Ulm, Germany +2 more locations

COMPLETEDPhase 2/3< 1 mile

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

NCT01110720

The purpose of the study is to evaluate the safety and efficacy of davunetide for the treatment of Progressive Supranuclear Palsy.

Progressive Supranuclear Palsy

Allon Therapeutics313 participantsStarted Oct 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +45 more locations

PreviousPage 3 of 3

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

ALS Trials in Other Cities

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Minocycline to Treat Amyotrophic Lateral Sclerosis

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Study of Electrical Impedance Myography (EIM) in ALS

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Other Conditions in Houston